Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of UWNKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

NCT04717999 is registered in ClinicalTrials.gov with UWELL Biopharma as lead sponsor.

NCT NCT04717999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of UWNKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
Lead sponsor
UWELL Biopharma
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2021
Completion date
December 31, 2023
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma